about
Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.Identification of disease-specific genes in chronic pancreatitis using DNA array technologyHsulf-1 regulates growth and invasion of pancreatic cancer cellsApoptosis: targets in pancreatic cancerPathways for aberrant angiogenesis in pancreatic cancerEffects of STI571 (gleevec) on pancreatic cancer cell growthCancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentHepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer ChallengeGenetically engineered mouse models of pancreatic adenocarcinomaRLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerTCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesisTumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer14-3-3sigma Modulates pancreatic cancer cell survival and invasivenessA mathematical model for pancreatic cancer growth and treatmentsCCL20/CCR6 expression profile in pancreatic cancerConcomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.Sensitization of human pancreatic cancer cells harboring mutated K-ras to apoptosismicroRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions.Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenograftsNADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phoxSCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cellsSmad4/DPC4-mediated tumor suppression through suppression of angiogenesis.Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasiaId-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitisTherapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus.Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1.Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers.Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distributionPancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.Pancreatic carcinogenesisReduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts.Smad4: gatekeeper gene in head and neck squamous cell carcinoma.KRas, ROS and the initiation of pancreatic cancerMitochondrial and Oxidative Stress-Mediated Activation of Protein Kinase D1 and Its Importance in Pancreatic CancerEpithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
P2860
Q24523684-9A3E126D-517E-43E2-9DB1-CC4CC51BE6DBQ24541958-E5D64B33-3F45-4175-BF49-C84A9C972EB2Q24675733-5C95C4B5-DE7D-424C-89D1-828CAD63F236Q24800170-98034788-8676-4133-B0F8-CA7B0C04A882Q24800215-249603AA-A2D4-45EC-9683-75556F9961CBQ24802841-4875673B-DC93-42C6-ABEC-9CC8F2AC7FFCQ26740619-14131888-BBE2-4BE4-9FA6-E45271B2EDE4Q26781273-6E8A4507-4893-48B7-8B99-B19F4C88C0AEQ27002973-2FDC9FD3-AC05-4C64-967F-314CFA783432Q28482104-EDB0A064-5F99-4195-9C2A-8F8951B0B8C5Q30908891-19C58452-162E-4C21-93C6-6CA82C3B6546Q33275720-AFE490E2-0A0E-48F1-8B7A-D8372A5575BFQ33388611-5CE46C95-9C9F-4849-8873-6202676FAA55Q33571981-ABD724A1-451C-4AE5-B9FE-01FE9540B0BEQ33878671-A72594C7-0D21-4FF0-B261-C04ADD00486EQ34326442-72E5EBB2-935D-483E-B4BC-225D54BEAD12Q34357907-51194C67-A335-4670-A50C-EC2BDD49FDBDQ34375528-E58BD542-CFF4-4D5A-A901-122F487E3B32Q34517052-8AB86736-590C-49A3-A504-7A7BB095AF4BQ34605758-B6517A01-20EC-4E06-B0FE-440E79CD977BQ34624105-9ED10D71-A039-435F-8B2B-A9F045C86F09Q35087762-09EF56EC-7A71-494F-9647-FE3C68E711E3Q35210772-9614B25F-93E2-4702-9ACD-AC86C455F89DQ35376826-CF761BC0-E537-4921-B569-8199DE08C6C8Q35787823-1061D53F-50D3-4C0A-AB15-F8E5DEA1AA9AQ35928932-15F4866C-2A37-4AAC-ADE6-5029CE72098CQ35951834-1BBB1251-97E5-4925-A47D-93C55E51D146Q36227239-5A2711C6-0BFF-4058-9A7F-57D9B6859876Q36456052-FCA4F7A3-BA50-4B1E-8046-C5ABD06741BAQ36643707-7F67D0BC-2402-42A6-8F86-CD0F222EB3CEQ36694770-1F3860E1-DA2F-478F-9BD2-1864857E0F8AQ36880450-3D17FF47-A86D-4300-83E0-E8490CDD7235Q37069243-ED7F6527-70DA-4C3D-BCFD-7AECDB1D6970Q37125627-E8892F74-B1FD-4014-9E7B-8FA742701621Q37145879-E6503F0A-6CC0-4AB2-AA02-54278FD05AE6Q37177892-F6D54B92-8779-409B-BC5B-52405C4FFD36Q37403133-25FD8D39-21FF-4CD9-B973-C1A89B094232Q37673906-971FDBD4-7D4C-4AC8-850D-26B4AEC73FD1Q37699563-BE12B9BC-C7E7-4B4B-8913-75260A60CDDCQ39090188-A5AF3B53-6FE4-4477-83E8-78942E040148
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Role of growth factors in pancreatic cancer.
@en
type
label
Role of growth factors in pancreatic cancer.
@en
prefLabel
Role of growth factors in pancreatic cancer.
@en
P1476
Role of growth factors in pancreatic cancer
@en
P2093
P356
10.1016/S1055-3207(18)30283-7
P577
1998-01-01T00:00:00Z